ATLergist Profile Banner
Brian Vickery Profile
Brian Vickery

@ATLergist

Followers
2K
Following
3K
Media
167
Statuses
2K

Dad, Husband (@jenamcgregor), A/I doc & team lead @childrensatl, @EmoryPediatrics. Innovation/implementation/outcomes/people. DO NOT let them steal your joy

ATL, GA
Joined May 2018
Don't wanna be here? Send us removal request.
@ATLergist
Brian Vickery
5 years
This is my new pinned tweet
@AleenaBanerjiMD
Aleena Banerji, MD
5 years
Many asking "which vaccine is better?" and it seems the answer right now is "whichever one is available to you first." #ThisIsOurShot #COVIDvaccine
Tweet media one
3
1
12
@ATLergist
Brian Vickery
9 months
Hey y'all come on over to B****sky where we're trying to make it like Old Twitter 🤣. I've got the same ATLergist handle, hit me up once you make the jump. https://t.co/Tld6OWlAU3
Tweet card summary image
science.org
After recent changes to Elon Musk’s X, a gradual migration turns into a stampede
0
0
2
@ATLergist
Brian Vickery
10 months
I choose to mark this moment by being intentional about reclaiming my attention and energy, and to focus them on positive things. I am deleting this app. Y’all be kind to one another.
2
0
7
@ATLergist
Brian Vickery
1 year
This should be front page news. We have effective medicines for asthma - the most common reason for childhood hospitalization - & kids don’t have access to them anymore. Because of business decisions made by companies. And kids are literally unnecessarily suffering & dying.
@elizabethmatsui
Elizabeth Matsui
1 year
Ripples from Flovent's discontinuation are killing children with asthma
0
7
20
@ATLergist
Brian Vickery
1 year
(sticks head up out of foxhole) Is it still a partisan clickbait hellscape out here masquerading as “free speech?” Thinking about a small scale reengagement deleting nearly all but a few follows…I miss the utility but not the outrage. Advice?
5
0
5
@ATLergist
Brian Vickery
2 years
This changes everything. 20 years after proof of concept for anti-IgE in food allergy, we now have an available treatment. Extremely proud of the 10 teams around the country who did this work, and incredibly grateful to the brave participants.
Tweet card summary image
wsj.com
Novartis and Roche Holding said the U.S. Food and Drug Administration approved their Xolair treatment to reduce allergic reactions following the exposure to one or more foods.
0
0
3
@ATLergist
Brian Vickery
2 years
👀👇🏻
@NEJMEvidence
NEJM Evidence
2 years
“… [the POSEIDON trial], along with its predecessors, creates a strong argument to support the use of oral immunotherapy in infants and young children with peanut allergy.” Read the editorial: https://t.co/meWHiXLyd6 #immunology #pediatrics
Tweet media one
0
1
4
@ATLergist
Brian Vickery
2 years
Come see us! We want to evaluate infants with eczema and/or food allergy(ies) as soon as we can. Treatments started early in life provide the best benefit! Learn more and make an appointment today at https://t.co/bUoo2CjEkI
@childrensatl
Children's
2 years
We are one step closer to a new oral treatment for our toddler peanut allergy patients thanks to research from Dr. Brian Vickery (@ATLergist) showing promising results with powder-dnfp (PTAH) oral immunotherapy. Learn more: https://t.co/cRPP56RBwx.
Tweet media one
0
3
15
@ATLergist
Brian Vickery
2 years
Repeat after me: early OIT is the best OIT. In some kids you may even be able to modify disease progression…see in this study how the IgE levels rise in the placebo but not active group 👀
@NEJMEvidence
NEJM Evidence
2 years
In peanut-allergic children 1 to <4 years of age treated with peanut allergen powder-dnfp for approximately 12 months, the majority tolerated all peanut protein dose levels assessed. Read more about the POSEIDON phase 3 trial results: https://t.co/GMvWMT96pa #immunology
Tweet media one
2
6
17
@ATLergist
Brian Vickery
2 years
👏🏻👏🏻👏🏻👏🏻👏🏻👏🏻
@wsbtv
WSB-TV
2 years
Atlanta rapper T.I. attended the ribbon-cutting ceremony for his first affordable apartment development on Tuesday.
0
0
0
@ATLergist
Brian Vickery
2 years
Correction! Job Fair at #ACAAI23 starts at 11:30! Come see us in booth 28 at the far back right of the exhibit hall. You can’t miss it 😎
Tweet media one
0
0
4
@ATLergist
Brian Vickery
2 years
TODAY! It’s Saturday at #ACAAI23 and while we all await with baited breath the plenary from @AllergyKidsDoc, a reminder: Come see us at the Job Fair from 11-3. Emory and Children’s are recruiting multiple opportunities for internists and pediatricians! @ACAAI
1
1
10
@ATLergist
Brian Vickery
2 years
Because we at @EmoryPediatrics and @childrensatl are hiring!! Come join an amazing and growing team in a fantastic place to live. DM me or come see me at the Job Fair if onsite this weekend. Please share to your followers & thanks 🙏🏻 (2/2) https://t.co/ixGbOTmjvf
0
0
5
@ATLergist
Brian Vickery
2 years
Right now thousands of folks from all over the country are flying to Anaheim for #ACAAI23. I will join them soon! I’m excited to give a couple presentations, including my first plenary talk. But, I’m equally excited to meet some candidates in the Job Fair on Saturday… (1/2)
1
0
21
@Nature
nature
2 years
A survey of thousands of US academics has found that the number one reason that women leave faculty positions is poor “workplace climate”, which can encompass discrimination, dysfunctional leadership, a feeling of not fitting in and other problems. More: https://t.co/U27agAZ14z
Tweet media one
9
296
550
@ATLergist
Brian Vickery
2 years
Very proud to have been a part of this international team evaluating peanut OIT in preschoolers - in my opinion the very highest and best use of this therapy. So much so that we have developed an early treatment program @childrensatl that is changing lives today.
@NEJMEvidence
NEJM Evidence
2 years
Just published: “Oral Immunotherapy for Peanut Allergy in Children 1 to Less Than 4 Years of Age” (POSEIDON phase 3 trial) by George Du Toit, MB, BCh (@GoAllergy), Brian P. Vickery, MD (@ATLergist), et al.: https://t.co/GMvWMT8yzC #immunology #pediatrics
Tweet media one
2
7
28
@ATLergist
Brian Vickery
2 years
We are hiring MULTIPLE allergy/immunology physicians @EmoryMedicine @emoryhealthcare @childrensatl @EmoryDeptofMed @EmoryPediatrics! We will have much more to come - including the #ACAAI23 job fair - but for internal medicine-trained candidates 👇 https://t.co/AZMEDxY8Rt or DM
0
2
10
@jacionline
Journal of Allergy and Clinical Immunology
2 years
The clinical prediction of food allergy reaction severity remains challenging. New data suggest that tryptase genotyping could be useful as a biomarker of patients with food allergy who are at risk for life-threatening reactions. Read on.
0
7
11
@ATLergist
Brian Vickery
2 years
I’ve been searching for a response to the brokenness of our world and, not finding anything suitable to say, have been quiet. Harari’s call to “make an effort to empathize with all suffering humans […] to help maintain a space for peace” resonates. May it one day be so. 🕊️☮️✌🏻
@harari_yuval
Yuval Noah Harari
2 years
Right now the minds of Israelis & Palestinians are filled with their own pain: no space left to even acknowledge the pain of the other side. But outsiders should make an effort to empathize with all suffering humans & help maintain a space for peace. https://t.co/3hmLy0m5EP @TIME
Tweet media one
0
0
3
@ATLergist
Brian Vickery
2 years
Congratulations @alex_fsantos for your tireless and expert effort leading this working group, of which I am immensely proud and grateful to be a very small part.
@alex_fsantos
Alexandra Santos
2 years
Very proud! The @EAACI_HQ guidelines on the diagnosis of IgE mediated food allergy have been published - for the first time IgE to allergen components and activation test are part of the list of recommended tests. Thank you to all the experts who contributed too many to name here
1
0
9
@AmbassadorRice
Susan Rice
2 years
There is only one moral response to Hamas’ horrific, atrocious terrorist attacks in Israel: unequivocal and forceful condemnation. There is never, ever any justification for terrorism against innocent civilians. Anywhere. Full stop. It’s unfathomable that many argue otherwise.
227
353
2K